Best TWAS P=3.66e-14 · Best GWAS P=3.15e-14 conditioned to 0.0179
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ARFGEF2 | 0.09 | 0.05 | lasso | 8 | 0.10 | 9.2e-13 | 7.6 | -7.6 | 3.7e-14 | -0.83 | 0.00 | 1.00 | TRUE |
2 | GTEx | Cells Transformed fibroblasts | STAU1 | 0.08 | 0.03 | lasso | 6 | 0.02 | 2.3e-02 | 5.2 | 6.1 | 1.3e-09 | 0.85 | 0.03 | 0.91 | FALSE |
3 | GTEx | Colon Sigmoid | CSE1L | 0.18 | 0.12 | lasso | 11 | 0.09 | 4.4e-04 | 5.8 | -5.9 | 4.7e-09 | -0.81 | 0.14 | 0.80 | FALSE |
4 | GTEx | Colon Transverse | ARFGEF2 | 0.11 | 0.07 | enet | 12 | 0.09 | 2.9e-05 | -1.9 | -5.3 | 1.3e-07 | -0.80 | 0.04 | 0.95 | FALSE |
5 | GTEx | Esophagus Mucosa | ZFAS1 | 0.15 | 0.01 | enet | 16 | 0.01 | 8.9e-02 | 6.5 | 5.6 | 2.8e-08 | 0.69 | 0.07 | 0.76 | FALSE |
6 | GTEx | Lung | CSE1L | 0.10 | 0.09 | lasso | 5 | 0.08 | 6.6e-07 | 5.3 | -5.3 | 1.0e-07 | -0.74 | 0.45 | 0.54 | FALSE |
7 | GTEx | Skin Sun Exposed Lower leg | CSE1L | 0.08 | 0.03 | lasso | 2 | 0.03 | 9.5e-04 | 5.8 | -5.4 | 6.7e-08 | -0.82 | 0.34 | 0.38 | FALSE |
8 | GTEx | Skin Sun Exposed Lower leg | ZFAS1 | 0.07 | 0.03 | enet | 14 | 0.05 | 5.8e-05 | 6.5 | 5.2 | 1.6e-07 | 0.78 | 0.18 | 0.76 | FALSE |
9 | GTEx | Testis | ARFGEF2 | 0.20 | 0.20 | lasso | 7 | 0.24 | 5.4e-11 | 5.3 | -6.7 | 2.2e-11 | -0.93 | 0.02 | 0.98 | FALSE |
10 | METSIM | Adipose | ARFGEF2 | 0.04 | 0.03 | lasso | 12 | 0.02 | 9.8e-05 | 7.5 | -7.1 | 1.5e-12 | -0.97 | 0.02 | 0.98 | FALSE |
11 | NTR | Blood | NCRNA00275 | 0.07 | 0.06 | lasso | 4 | 0.08 | 9.7e-25 | -2.6 | -5.3 | 9.6e-08 | -0.52 | 1.00 | 0.00 | FALSE |
12 | NTR | Blood | SNORD12B | 0.03 | 0.05 | lasso | 8 | 0.05 | 1.9e-14 | 6.5 | -7.0 | 3.6e-12 | -0.95 | 0.11 | 0.89 | FALSE |
13 | The Cancer Genome Atlas | Breast Invasive Carcinoma | STAU1 | 0.01 | 0.01 | blup | 54 | 0.01 | 6.1e-03 | -4.3 | -5.5 | 4.1e-08 | -0.45 | 0.03 | 0.13 | FALSE |
14 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CSE1L | 0.03 | 0.05 | lasso | 1 | 0.03 | 9.3e-05 | 5.2 | -5.2 | 1.7e-07 | -0.76 | 0.30 | 0.61 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CSE1L | 0.05 | 0.07 | blup | 50 | 0.07 | 3.2e-08 | 5.7 | -5.4 | 6.5e-08 | -0.81 | 0.39 | 0.61 | FALSE |
16 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ARFGEF2 | 0.05 | 0.04 | lasso | 5 | 0.05 | 3.2e-06 | 7.6 | -7.0 | 2.0e-12 | -0.95 | 0.00 | 1.00 | FALSE |
17 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C20orf199 | 0.05 | 0.06 | lasso | 4 | 0.06 | 1.0e-04 | 6.6 | 6.6 | 5.7e-11 | 0.91 | 0.00 | 0.96 | FALSE |
18 | The Cancer Genome Atlas | Thyroid Carcinoma | ARFGEF2 | 0.06 | 0.01 | blup | 79 | 0.03 | 4.2e-04 | -3.8 | -5.4 | 6.2e-08 | -0.43 | 0.75 | 0.05 | FALSE |
19 | The Cancer Genome Atlas | Thyroid Carcinoma | DDX27 | 0.08 | 0.05 | lasso | 3 | 0.05 | 1.9e-05 | 6.5 | 5.4 | 7.3e-08 | 0.85 | 0.06 | 0.90 | FALSE |